Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

OBJECTIVE: The aim of this study was to determine the optimal patient-reported outcome measure (PROM) for assessing symptom benefit in trials of palliative chemotherapy for women with symptomatic ovarian cancer. METHODS: Candidate PROMs were EORTC QLQ-C30 plus ovarian-specific QLQ-OV28, Functional A...

Descripció completa

Dades bibliogràfiques
Autors principals:	King, M, Stockler, MR, Butow, P, O'Connell, R, Voysey, M, Oza, A, Gillies, K, Donovan, H, Mercieca-Bebber, R, Martyn, J, Sjoquist, K, Friedlander, M
Format:	Journal article
Idioma:	English
Publicat:	Lippincott Williams and Wilkins 2014

Ítems similars

Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study.
per: Friedlander, M, et al.
Publicat: (2014)

Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.
per: Sjoquist, K, et al.
Publicat: (2013)

Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice
per: Campbell R, et al.
Publicat: (2023-05-01)

The importance of patient-reported outcomes in clinical trials and strategies for future optimization
per: Mercieca-Bebber R, et al.
Publicat: (2018-11-01)

Symptoms Relevant to Surveillance for Ovarian Cancer
per: Robert M. Ore, et al.
Publicat: (2017-03-01)

Symptom interpretation and health care seeking in ovarian cancer
per: Blaakaer Jan, et al.
Publicat: (2011-06-01)

Assessment of early symptoms of surgical menopause in patients with borderline ovarian tumors
per: A. Yu. Vlasina, et al.
Publicat: (2020-09-01)

Identifying symptoms of ovarian cancer: a qualitative and quantitative study.
per: Bankhead, C, et al.
Publicat: (2008)

Symptoms associated with diagnosis of ovarian cancer: a systematic review.
per: Bankhead, C, et al.
Publicat: (2005)

Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor.
per: Price, M, et al.
Publicat: (2009)

An Updated Systematic Review of Quantitative Studies Assessing Anxiety, Depression, Fear of Cancer Recurrence or Psychological Distress in Testicular Cancer Survivors
per: Rincones O, et al.
Publicat: (2021-05-01)

Modified Goff Symptom Index : Simple triage tool for ovarian malignancy
per: Jyothi Shetty, et al.
Publicat: (2015-08-01)

Influences on anticipated time to ovarian cancer symptom presentation in women at increased risk compared to population risk of ovarian cancer
per: Stephanie Smits, et al.
Publicat: (2017-12-01)

Symptomatic Isolated Pleural Effusion as an Atypical Presentation of Ovarian Hyperstimulation Syndrome
per: Christine M. Mullin, et al.
Publicat: (2011-01-01)

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
per: Katrin M. Sjoquist, et al.
Publicat: (2018-08-01)

Signs and symptoms, evaluation, and management of genitourinary tract consequences of premature ovarian insufficiency
per: Anna Calik-Ksepka, et al.
Publicat: (2018-09-01)

Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
per: Eduardo Gonzalez-Ochoa, et al.
Publicat: (2023-07-01)

Marked hypereosinophilia secondary to endometrioid ovarian cancer presenting with asthma symptoms, a case report
per: Hasan Ahmad Hasan Albitar, et al.
Publicat: (2020-01-01)

Exploring Self-Reported Symptoms for Developing and Evaluating Digital Symptom Checkers for Polycystic Ovarian Syndrome, Endometriosis, and Uterine Fibroids: Exploratory Survey Study
per: Aidan P Wickham, et al.
Publicat: (2024-12-01)

Effect of Weight Loss on Symptoms of Polycystic Ovarian Syndrome among Women of Reproductive Age
per: Anita Dileep, et al.
Publicat: (2021-04-01)

Knowledge toward ovarian cancer symptoms among women in Syria: Cross-sectional study
per: Haidara Bohsas, et al.
Publicat: (2023-08-01)

Delphi survey to inform patient-reported symptom monitoring after ovarian cancer treatment
per: Leanne Shearsmith, et al.
Publicat: (2020-08-01)

Women’s Knowledge on Ovarian Cancer Symptoms and Risk Factors in Nigeria: An Institutional-based Study
per: Adeyemi Adebola Okunowo, et al.
Publicat: (2018-12-01)

Women's awareness of ovarian cancer risk factors and symptoms in Western Iran in 2020–2021
per: Babaei Maryam, et al.
Publicat: (2022-05-01)

Bilateral ovarian artery embolization for a symptomatic large cervical fibroid
per: William D. Denton, MA, et al.
Publicat: (2024-12-01)

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?
per: Hallowell N, et al.
Publicat: (2012-04-01)

Rheumatoid arthritis: A major symptom and symptomatic therapy
per: Yuri Aleskandrovich Olyunin
Publicat: (2014-12-01)

Reliability of salivary testosterone measurements in diagnosis of Polycystic Ovarian Syndrome
per: Omnia Youssef, et al.
Publicat: (2010-07-01)

Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis
per: Arpita Suri, et al.
Publicat: (2021-08-01)

Risk of ovarian cancer in women with symptoms in primary care: population based case-control study
per: Hamilton, W, et al.
Publicat: (2009)

Risk of ovarian cancer in women with symptoms in primary care: population based case-control study.
per: Hamilton, W, et al.
Publicat: (2009)

A longitudinal study of symptom cluster latent profiles in ovarian cancer patients undergoing chemotherapy
per: Yue Feng, et al.
Publicat: (2024-04-01)

Awareness of ovarian cancer symptoms and risk factors in a young ethnically diverse British population
per: Cristina‐Alexandra Radu, et al.
Publicat: (2023-04-01)

Examining the Effect of Chamomile on Clinical Symptoms and Hormonal Parameters Among Patients With Polycystic Ovarian Syndrome
per: Malihe Afiat, et al.
Publicat: (2022-12-01)

Residual ovarian syndrome: A case report with classic symptoms, imaging and pathology findings, and treatment
per: Shao-Chi Fu, et al.
Publicat: (2018-10-01)

Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women
per: Autelitano Dominic J, et al.
Publicat: (2012-03-01)

Development of the Weight-Related Sign and Symptom Measure
per: Meryl Brod, et al.
Publicat: (2018-04-01)

Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists
per: Junhan Jiang, et al.
Publicat: (2021-12-01)

The multidimensional measurement of the positive symptoms of psychosis.
per: Steel, C, et al.
Publicat: (2007)

Assessing awareness of blood cancer symptoms and barriers to symptomatic presentation: measure development and results from a population survey in the UK
per: Laura Boswell, et al.
Publicat: (2023-07-01)